AIM ImmunoTech (AIM) Return on Sales [ROS] (2010 - 2026)
AIM ImmunoTech's Return on Sales [ROS] came in at -13511.54% for Q2 2026, down 2927.54 percentage points from -10584.00% a year earlier and down 3393.36 percentage points from the prior quarter.
AIM ImmunoTech (AIM) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, AIM ImmunoTech reported Return on Sales [ROS] of -11724.21%, up 2002.24 percentage points year-over-year; for FY2025, it came in at -13254.55%, down 1623.96 percentage points from FY2024.
- Return on Sales [ROS] carries a five-year change of -3958.84 percentage points (FY2020 to FY2025).
- Going back by year, Return on Sales [ROS] was -11630.59% in FY2024 (+4169.41 pp), -15800.00% in FY2023 (-1670.21 pp), -14129.79% in FY2022 (-175.71 pp) and -13954.07% in FY2021 (-4658.37 pp).
- The five-year range for quarterly Return on Sales [ROS] is -31052.38% (Q3 2022) to -7388.00% (Q2 2024).
- Year-over-year, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of +1737.73 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q3 2023 (a gain of 13319.77 percentage points), and the weakest in Q3 2022 (a drop of 19146.32 percentage points).
- Business Quant data shows AIM's Return on Sales [ROS] at -10118.18% (Q1 2026), -14057.14% (Q4 2025) and -9411.54% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 28.37% |
| 10 | AIM ImmunoTech | 3.25 Mn | -18.05 Mn | 21,000.00 | -13,511.54% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13,511.54% |
| Mar 31, 2026 | -10,118.18% |
| Dec 31, 2025 | -14,057.14% |
| Sep 30, 2025 | -9,411.54% |
| Jun 30, 2025 | -10,584.00% |
| Mar 31, 2025 | -22,618.75% |
| Dec 31, 2024 | -13,011.11% |
| Sep 30, 2024 | -12,825.71% |
| Jun 30, 2024 | -7,388.00% |
| Mar 31, 2024 | -14,335.00% |
| Dec 31, 2023 | -21,544.62% |
| Sep 30, 2023 | -17,732.61% |
| Jun 30, 2023 | -13,002.38% |
| Mar 31, 2023 | -8,765.31% |
| Dec 31, 2022 | -9,921.43% |
| Sep 30, 2022 | -31,052.38% |
| Jun 30, 2022 | -15,650.00% |
| Mar 31, 2022 | -9,551.52% |
| Dec 31, 2021 | -14,890.00% |
| Sep 30, 2021 | -11,906.06% |
AIM ImmunoTech Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();